LumiraDx (LumiraDx) Ending Cash Position : $25.3 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Ending Cash Position?

LumiraDx's Ending Cash Position for the quarter that ended in Jun. 2023 was $25.3 Mil.

LumiraDx's quarterly Ending Cash Position declined from Dec. 2022 ($100.0 Mil) to Mar. 2023 ($68.1 Mil) and declined from Mar. 2023 ($68.1 Mil) to Jun. 2023 ($25.3 Mil).

LumiraDx's annual Ending Cash Position declined from Dec. 2020 ($161.2 Mil) to Dec. 2021 ($132.1 Mil) and declined from Dec. 2021 ($132.1 Mil) to Dec. 2022 ($100.0 Mil).

LumiraDx Ending Cash Position Historical Data

The historical data trend for LumiraDx's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Ending Cash Position Chart

LumiraDx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Ending Cash Position

139.39

161.17

132.15

100.01

LumiraDx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Ending Cash Position	Get a 7-Day Free Trial								106.45	135.27	100.01	68.05	25.34

LumiraDx Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

LumiraDx's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	132.145	+	-32.135
	=	100.0

LumiraDx's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	68.051	+	-42.708
	=	25.3

LumiraDx Ending Cash Position Related Terms

Thank you for viewing the detailed overview of LumiraDx's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

LumiraDx (LumiraDx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDXF) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108

Website

https://www.lumiradx.com

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.